Clinical Trials Browser

Brain Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

NCT00843037 2024-10-17

SNIPP

Phase 2 Completed

25 enrolled 19 charts

CNSEndocrine

Neoplasm Metastasis, Paraganglioma, Pheochromocytoma

NCT00981890 2022-10-07

Stereotactic Radiosurgery With Sunitinib for Brain Metastases

Phase 1 Completed

22 enrolled

CNS

Brain Neoplasms

NCT01371201 2022-08-04

FIRSTMAPPP

Phase 2 Completed

78 enrolled

CNSEndocrine

Paraganglioma

NCT00864864 2016-07-07

Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

Phase EARLY_PHASE1 Completed

8 enrolled

CNS

Brain Neoplasms, Glioblastoma

NCT00499473 2016-02-29

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Phase 2 Completed

31 enrolled 6 charts

CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

NCT00462982 2015-12-30

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Phase 2 Completed

8 enrolled 6 charts

CNSDermatologicGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma, Neoplasm Metastasis

NCT01462695 2015-08-27

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Phase 2 Completed

30 enrolled 8 charts

CNS

Familial ependymoma, Astrocytoma, Oligodendroglioma

NCT00611728 2014-07-21

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Phase 1 Completed

25 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT00387920 2014-01-28

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

35 enrolled

CNSOther solid neoplasm

Central Nervous System Metastases

NCT01100177 2013-03-11

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

Phase 2 Completed

12 enrolled

CNS

Glioblastoma

NCT00606008 2012-11-19

A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma

Phase 2 Completed

30 enrolled 8 charts

CNS

Astrocytoma, Glioblastoma

NCT00372775 2011-02-24

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Phase 2 Completed

66 enrolled 21 charts

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

SNIPP

Stereotactic Radiosurgery With Sunitinib for Brain Metastases

FIRSTMAPPP

Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients

A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases